Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Benjamin B Gelman

1-50 of 81 results

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

scientific article published on December 21, 2010

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

scientific article published on January 2008

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

scientific article published on September 10, 2011

Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.

scientific article published in September 2004

Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study

scientific article published on May 2010

Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study

scientific article published on October 31, 2014

Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline

scientific article

Clinical factors related to brain structure in HIV: the CHARTER study

scientific article published on May 5, 2011

The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment

scientific article

Diagnosing Symptomatic HIV-Associated Neurocognitive Disorders: Self-Report Versus Performance-Based Assessment of Everyday Functioning

scientific article published on November 24, 2011

Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment

scientific article published on September 2004

Chronic-Pain-Associated Astrocytic Reaction in the Spinal Cord Dorsal Horn of Human Immunodeficiency Virus-Infected Patients

scientific article published on August 8, 2012

Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change

scientific article

Neurocognitive Impact of Substance Use in HIV Infection

scientific article published on October 1, 2011

Efavirenz concentrations in CSF exceed IC50 for wild-type HIV

scientific article published on November 23, 2010

Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort

scientific article published on April 2013

Low atazanavir concentrations in cerebrospinal fluid

scientific article published on January 2009

Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered

scientific article published on June 2015

Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers

scientific article published on November 2012

Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir

scientific article published in April 2012

Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy

scientific article

Prefrontal Dopaminergic and Enkephalinergic Synaptic Accommodation in HIV-associated Neurocognitive Disorders and Encephalitis

scientific article published on March 6, 2012

Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients

scientific article published on September 25, 2015

Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1.

scientific article

Lifetime suicidal ideation and attempt are common among HIV+ individuals

scientific article published on 23 July 2011

Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes

scientific article

Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease

scientific article (publication date: 13 February 2013)

Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection

scientific article published on 10 July 2013

Persistent hijacking of brain proteasomes in HIV-associated dementia

scientific article

Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders

scientific article

Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders.

scientific article

Gp120 in the pathogenesis of human immunodeficiency virus–associated pain

scientific article published on May 28, 2014

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy

scientific article

Molecular confirmation of Sappinia pedata as a causative agent of amoebic encephalitis

scientific article

The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV.

scientific article

p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28.

scientific article

Astrocyte Elevated Gene-1 Is a Novel Modulator of HIV-1-associated Neuroinflammation via Regulation of Nuclear Factor-κB Signaling and Excitatory Amino Acid Transporter-2 Repression

scientific article published on May 22, 2014

CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease

scientific article published on 12 June 2015

Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people

scientific article published on December 10, 2014

Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration

scientific article published on November 9, 2012

The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system

scientific article published on 3 January 2007

Quantitative neuropathology associated with chronic manganese exposure in South African mine workers

journal article published in 2014

Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder

scientific article

Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration

scientific article

Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity

scientific article

Substance abuse increases the risk of neuropathy in an HIV‐infected cohort

scientific article published on April 1, 2012

The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients

scientific article published on July 31, 2015

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection

scientific article

Relationship of Medication Management Test-Revised (MMT-R) Performance to Neuropsychological Functioning and Antiretroviral Adherence in Adults with HIV

scientific article published on November 1, 2012

Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study

scientific article